Albany, NY -- (SBWIRE) -- 07/22/2016 -- Multiple Sclerosis - Pipeline Review, H1 2016

Summary

Global Markets Directs, Multiple Sclerosis - Pipeline Review, H1 2016, provides an overview of the Multiple Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Multiple Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Multiple Sclerosis and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

View Report At: http://www.marketresearchreports.biz/analysis/751732

Scope

- The report provides a snapshot of the global therapeutic landscape of Multiple Sclerosis

- The report reviews pipeline therapeutics for Multiple Sclerosis by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Multiple Sclerosis therapeutics and enlists all their major and minor projects

- The report assesses Multiple Sclerosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Multiple Sclerosis

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/751732

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Multiple Sclerosis

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Multiple Sclerosis pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents
Table of Contents 2
Introduction 10
Multiple Sclerosis Overview 11
Therapeutics Development 12
Multiple Sclerosis - Therapeutics under Development by Companies 14
Multiple Sclerosis - Therapeutics under Investigation by Universities/Institutes 30
Multiple Sclerosis - Pipeline Products Glance 32
Multiple Sclerosis - Products under Development by Companies 36
Multiple Sclerosis - Products under Investigation by Universities/Institutes 56
Multiple Sclerosis - Companies Involved in Therapeutics Development 59
Multiple Sclerosis - Therapeutics Assessment 237
Drug Profiles 290
Multiple Sclerosis - Dormant Projects 828
Multiple Sclerosis - Discontinued Products 852
Multiple Sclerosis - Product Development Milestones 857
Appendix 868

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Contact
Mr. Nachiket
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Tel: 518-621-2074
Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz